DEVELOPMENT OF A TOPICAL GEL CONTAINING A DIPEPTIDYL PEPTIDASE-4 INHIBITOR FOR WOUND HEALING APPLICATIONS

16th August 2022; 11th January 2023; 22nd February 2023; 06th March 2023

Authors

  • Phawini Pokrathok M.S., Department of Chemical Engineering, Faculty of Engineering, King Mongkut’s University of Technology Thonburi, Bangkok, Thailand
  • Pornprom Muangman M.D., Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
  • Nantaporn Namviriyachote Ph.D., Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
  • Kwanchanok Viravaidya-Pasuwat Ph.D., Department of Chemical Engineering, Faculty of Engineering, King Mongkut’s University of Technology Thonburi, Bangkok, Thailand

DOI:

https://doi.org/10.20319/mijst.2023.9.2034

Keywords:

Carbopol 940, Chronic Wounds, DPP-4 Inhibitor, Kinetic Model, Sitagliptin

Abstract

Chronic wounds are challenging for healthcare because they are difficult to treat and cannot heal by themselves. Active compounds that can accelerate wound healing are, therefore, necessary. Dipeptidyl peptidase (DPP)-4 inhibitors are antihyperglycemic drugs widely used in patients with type 2 diabetes that not only maintain the homeostasis of blood sugar levels but have also been shown to promote chronic wound healing. In this study, we formulated a topical gel containing, sitagliptin, a commonly used DPP-4 inhibitor drug to treat diabetes, using Carbopol 940 as a base due to its high viscosity and biocompatibility. The characteristics of the sitagliptin gel, including its physical appearance, viscoelastic properties, swelling and degradation, and stability, were investigated. The gel appeared to be transparent with a uniform distribution of drug molecules and was stable at 4 °C for more than 1 month. Moreover, the gel was shown to exhibit shear thinning pseudoplastic behavior, which is desirable for topical gels. The gel could absorb up to 250% of liquid within 2 days but later degraded in aqueous solution following zeroth-order kinetics. In the in vitro release study, the cumulative release data were best fitted with the first order kinetic model, in which the release rate depended on the concentration. To further demonstrate the use of the DPP-4 inhibitor gel, the gel was applied directly onto subcutaneous wounds on experimental pigs. The topical gel was shown to exhibit the desired spread ability without causing any inflammation around the wound area which was comparable to IntraSite® gel and commercial silver nanoparticle cream.

References

Chandrashekar, K., Rajashekar, Y.R., & Ganesan, R. (2017). Evaluation of dipeptidyl peptidase-4 enzyme inhibition by some commonly used gliptins on cutaneous wound healing in albino rats. National Journal of Physiology, Pharmacy and Pharmacology, 7, 1. https://doi.org/10.5455/njppp.2017.7.0832224082017

Dhivya, S., Padma, V. V., & Santhini, E. (2015). Wound dressings - a review. BioMedicine, 5(4), 22-22. https://doi.org/10.7603/s40681-015-0022-9

Frykberg, R., & Banks, J. (2015). Challenges in the Treatment of Chronic Wounds. Advances in wound care, 4, 560-582. https://doi.org/10.1089/wound.2015.0635

Hayati, F., Ghamsari, S. M., Dehghan, M. M., & Oryan, A. (2018). Effects of carbomer 940 hydrogel on burn wounds: an in vitro and in vivo study. J Dermatolog Treat, 29(6), 593-599. https://doi.org/10.1080/09546634.2018.1426823

Karki, S., Kim, H., Na, S.-J., Shin, D., Jo, K., & Lee, J. (2016). Thin films as an emerging platform for drug delivery. Asian Journal of Pharmaceutical Sciences, 11(5), 559-574. https://doi.org/https://doi.org/10.1016/j.ajps.2016.05.004

Kujath, P., & Michelsen, A. (2008). Wounds - from physiology to wound dressing. Deutsches Arzteblatt international, 105(13), 239-248. https://doi.org/10.3238/arztebl.2008.0239

Long, M., Cai, L., Li, W., Zhang, L., Guo, S., Zhang, R., Zheng, Y., Liu, X., Wang, M., Zhou, X., Wang, H., Li, X., Li, L., Zhu, Z., Yang, G., & Zheng, H. (2018). DPP-4 Inhibitors Improve Diabetic Wound Healing via Direct and Indirect Promotion of Epithelial-Mesenchymal Transition and Reduction of Scarring. Diabetes, 67(3), 518-531. https://doi.org/10.2337/db17-0934

Nan, N. F. C., Zainuddin, N., & Ahmad, M. (2019). Preparation and swelling study of CMC hydrogel as potential superabsorbent. Pertanika Journal of Science and Technology, 27, 489-498.

Rüther, L., & Voss, W. (2021). Hydrogel or ointment? Comparison of five different galenics regarding tissue breathability and transepidermal water loss. Heliyon, 7(1), e06071. https://doi.org/https://doi.org/10.1016/j.heliyon.2021.e06071

Shaikh, H., Kshirsagar, R., & Patil, S. G. (2015). Mathematical Models for Drug Release Characterization: A Review.

Shih, C. M., Huang, C. Y., Huang, C. Y., Wang, K. H., Wei, P. L., Chang, Y. J., Fong, T. H., Pan, J. L., & Lee, A. W. (2018, Oct). A dipeptidyl peptidase-4 inhibitor promotes wound healing in normoglycemic mice by modulating keratinocyte activity. Exp Dermatol, 27(10), 1134-1141. https://doi.org/10.1111/exd.13751

Vishal, T., & Manish, G. (2013). Rheological Study of Diclofenac Gel Containing Different Concentration of Carbapol 940.

Downloads

Published

2023-03-15

How to Cite

Pokrathok, P., Muangman, P., Namviriyachote, N., & Viravaidya-Pasuwat, K. (2023). DEVELOPMENT OF A TOPICAL GEL CONTAINING A DIPEPTIDYL PEPTIDASE-4 INHIBITOR FOR WOUND HEALING APPLICATIONS: 16th August 2022; 11th January 2023; 22nd February 2023; 06th March 2023. MATTER: International Journal of Science and Technology, 9, 20–34. https://doi.org/10.20319/mijst.2023.9.2034

Issue

Section

Articles